Charles Theuer 4 D Molecular Therapeutics, Inc. (FDMT) insider trading activity

FDMT Quotes by TradingView

Charles Theuer is of 4D Molecular Therapeutics, Inc.. Currently has a direct ownership of 41,684 shares of FDMT, which is worth approximately $452,271. The most recent transaction as insider was on Dec 12, 2025, when has been sold 9,333 shares (Common Stock) at a price of $1.14 per share, resulting in proceeds of $10,639. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41.7K
n/a 3M change
n/a 12M change
Total Value Held $452,271

CHARLES THEUER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 12 2025
BUY
Exercise of conversion of derivative security
$10,639 $1.14 p/Share
9,333 Added 18.29%
41,684 Common Stock

Also insider at

TCON
Tracon Pharmaceuticals, Inc. Healthcare
PRESIDENT AND CEO
ONCT
Oncternal Therapeutics, Inc. Healthcare
CT

Charles Theuer

San Diego, CA

Track Institutional and Insider Activities on FDMT

Follow 4D Molecular Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FDMT shares.

Notify only if

Insider Trading

Get notified when an 4 D Molecular Therapeutics, Inc. insider buys or sells FDMT shares.

Notify only if

News

Receive news related to 4D Molecular Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on FDMT